Cardiovascular safety of tyrosine kinase inhibitors: Putting their "QT-phobia" in perspective
Many potentially valuable drugs, including protein kinase inhibitors (PKI), risk being dropped from further development, without exploration of their clinical benefits, if early studies show these drugs to inhibit hERG channel and therefore, to have a potential for prolonging ventricular repolarisat...
Sparad:
| Huvudskapare: | |
|---|---|
| Materialtyp: | Bok |
| Publicerad: |
International Association of Physical Chemists (IAPC),
2016-10-01T00:00:00Z.
|
| Ämnen: | |
| Länkar: | Connect to this object online. |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signum: |
A1234.567 |
|---|---|
| Exemplar 1 | Tillgänglig |